Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2008-09-25

FDA Approved: VASERETIC — Supplemental Application (Bausch Health US, LLC)

View source ↗

Summary

FDA approved a supplemental application for VASERETIC (enalapril maleate and hydrochlorothiazide) submitted by Bausch Health US, LLC, reflecting updated labelin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VASERETIC (Enalapril maleate and hydrochlorothiazide)

Snippet

SUPPL AP for VASERETIC (ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE)